These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 34805637)

  • 21. Cost-effectiveness frameworks for comparing genome and exome sequencing versus conventional diagnostic pathways: A scoping review and recommended methods.
    Ferket BS; Baldwin Z; Murali P; Pai A; Mittendorf KF; Russell HV; Chen F; Lynch FL; Lich KH; Hindorff LA; Savich R; Slavotinek A; Smith HS; Gelb BD; Veenstra DL
    Genet Med; 2022 Oct; 24(10):2014-2027. PubMed ID: 35833928
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A cost-effectiveness analysis of genomic sequencing in a prospective versus historical cohort of complex pediatric patients.
    Yeung A; Tan NB; Tan TY; Stark Z; Brown N; Hunter MF; Delatycki M; Stutterd C; Savarirayan R; Mcgillivray G; Stapleton R; Kumble S; Downie L; Regan M; Lunke S; Chong B; Phelan D; Brett GR; Jarmolowicz A; Prawer Y; Valente G; Smagarinsky Y; Martyn M; McEwan C; Goranitis I; Gaff C; White SM
    Genet Med; 2020 Dec; 22(12):1986-1993. PubMed ID: 32773771
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Early referral strategies for management of people with markers of renal disease: a systematic review of the evidence of clinical effectiveness, cost-effectiveness and economic analysis.
    Black C; Sharma P; Scotland G; McCullough K; McGurn D; Robertson L; Fluck N; MacLeod A; McNamee P; Prescott G; Smith C
    Health Technol Assess; 2010 Apr; 14(21):1-184. PubMed ID: 20441712
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Clinical Workflow for Cost-Saving High-Rate Diagnosis of Genetic Kidney Diseases.
    Becherucci F; Landini S; Palazzo V; Cirillo L; Raglianti V; Lugli G; Tiberi L; Dirupo E; Bellelli S; Mazzierli T; Lomi J; Ravaglia F; Sansavini G; Allinovi M; Giannese D; Somma C; Spatoliatore G; Vergani D; Artuso R; Rosati A; Cirami C; Dattolo PC; Campolo G; De Chiara L; Papi L; Vaglio A; Lazzeri E; Anders HJ; Mazzinghi B; Romagnani P
    J Am Soc Nephrol; 2023 Apr; 34(4):706-720. PubMed ID: 36753701
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of B-Type Natriuretic Peptide (BNP) and N-Terminal proBNP (NT-proBNP) as Diagnostic Tests in Adults With Suspected Heart Failure: A Health Technology Assessment.
    Ontario Health (Quality)
    Ont Health Technol Assess Ser; 2021; 21(2):1-125. PubMed ID: 34055110
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genomic sequencing for the diagnosis of childhood mitochondrial disorders: a health economic evaluation.
    Wu Y; Balasubramaniam S; Rius R; Thorburn DR; Christodoulou J; Goranitis I
    Eur J Hum Genet; 2022 May; 30(5):577-586. PubMed ID: 34099885
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multi-gene Pharmacogenomic Testing That Includes Decision-Support Tools to Guide Medication Selection for Major Depression: A Health Technology Assessment.
    Ontario Health (Quality)
    Ont Health Technol Assess Ser; 2021; 21(13):1-214. PubMed ID: 34484487
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cost of exome analysis in patients with intellectual disability: a micro-costing study in a French setting.
    Soilly AL; Robert-Viard C; Besse C; Bruel AL; Gerard B; Boland A; Piton A; Duffourd Y; Muller J; Poë C; Jouan T; El Doueiri S; Faivre L; Bacq-Daian D; Isidor B; Genevieve D; Odent S; Philip N; Doco-Fenzy M; Lacombe D; Asensio ML; Deleuze JF; Binquet C; ; Thauvin-Robinet C; Lejeune C
    BMC Health Serv Res; 2023 Apr; 23(1):386. PubMed ID: 37085862
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interferon gamma release assays for Diagnostic Evaluation of Active tuberculosis (IDEA): test accuracy study and economic evaluation.
    Takwoingi Y; Whitworth H; Rees-Roberts M; Badhan A; Partlett C; Green N; Boakye A; Lambie H; Marongiu L; Jit M; White P; Deeks JJ; Kon OM; Lalvani A
    Health Technol Assess; 2019 May; 23(23):1-152. PubMed ID: 31138395
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Point-of-care creatinine tests to assess kidney function for outpatients requiring contrast-enhanced CT imaging: systematic reviews and economic evaluation.
    Corbett M; Duarte A; Llewellyn A; Altunkaya J; Harden M; Harris M; Walker S; Palmer S; Dias S; Soares M
    Health Technol Assess; 2020 Aug; 24(39):1-248. PubMed ID: 32840478
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Exome sequencing as the first-tier test for pediatric respiratory diseases: A single-center study.
    Hao C; Guo R; Liu J; Hu X; Guo J; Yao Y; Zhao Z; Qi Z; Yin J; Chen L; Wang H; Xu B; Li W
    Hum Mutat; 2021 Jul; 42(7):891-900. PubMed ID: 33942430
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Economic evaluation of next-generation sequencing techniques in diagnosis of genetic disorders: A systematic review.
    Rezapour A; Souresrafil A; Barzegar M; Sheikhy-Chaman M; Tatarpour P
    Clin Genet; 2023 May; 103(5):513-528. PubMed ID: 36808726
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Elucigene FH20 and LIPOchip for the diagnosis of familial hypercholesterolaemia: a systematic review and economic evaluation.
    Sharma P; Boyers D; Boachie C; Stewart F; Miedzybrodzka Z; Simpson W; Kilonzo M; McNamee P; Mowatt G
    Health Technol Assess; 2012; 16(17):1-266. PubMed ID: 22469073
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy and economics of targeted panel versus whole-exome sequencing in 878 patients with suspected primary immunodeficiency.
    Platt CD; Zaman F; Bainter W; Stafstrom K; Almutairi A; Reigle M; Weeks S; Geha RS; Chou J;
    J Allergy Clin Immunol; 2021 Feb; 147(2):723-726. PubMed ID: 32888943
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Does genomic sequencing early in the diagnostic trajectory make a difference? A follow-up study of clinical outcomes and cost-effectiveness.
    Stark Z; Schofield D; Martyn M; Rynehart L; Shrestha R; Alam K; Lunke S; Tan TY; Gaff CL; White SM
    Genet Med; 2019 Jan; 21(1):173-180. PubMed ID: 29765138
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A scoping study to explore the cost-effectiveness of next-generation sequencing compared with traditional genetic testing for the diagnosis of learning disabilities in children.
    Beale S; Sanderson D; Sanniti A; Dundar Y; Boland A
    Health Technol Assess; 2015 Jun; 19(46):1-90. PubMed ID: 26132578
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cost-effectiveness of genome-wide sequencing for unexplained developmental disabilities and multiple congenital anomalies.
    Li C; Vandersluis S; Holubowich C; Ungar WJ; Goh ES; Boycott KM; Sikich N; Dhalla I; Ng V
    Genet Med; 2021 Mar; 23(3):451-460. PubMed ID: 33110268
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combined population genomic screening for three high-risk conditions in Australia: a modelling study.
    Lacaze P; Marquina C; Tiller J; Brotchie A; Kang YJ; Merritt MA; Green RC; Watts GF; Nowak KJ; Manchanda R; Canfell K; James P; Winship I; McNeil JJ; Ademi Z
    EClinicalMedicine; 2023 Dec; 66():102297. PubMed ID: 38192593
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    Ontario Health (Quality)
    Ont Health Technol Assess Ser; 2021; 21(14):1-186. PubMed ID: 34484488
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.